These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 35751930)

  • 1. MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review.
    Ahmed JQ; Maulud SQ; Dhawan M; Priyanka ; Choudhary OP; Jalal PJ; Ali RK; Tayib GA; Hasan DA
    J Infect Public Health; 2022 Jul; 15(7):788-799. PubMed ID: 35751930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
    Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
    Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Analysis of Targeting SARS-CoV-2, Viral Entry Proteins ACE2 and TMPRSS2, and Interferon Genes by Host MicroRNAs.
    Pierce JB; Simion V; Icli B; Pérez-Cremades D; Cheng HS; Feinberg MW
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19.
    Hum C; Loiselle J; Ahmed N; Shaw TA; Toudic C; Pezacki JP
    Drugs; 2021 Apr; 81(5):517-531. PubMed ID: 33638807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?
    Guterres A; de Azeredo Lima CH; Miranda RL; Gadelha MR
    Infect Genet Evol; 2020 Nov; 85():104417. PubMed ID: 32526370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential COVID-19 therapeutic approaches targeting angiotensin-converting enzyme 2; An updated review.
    Zanganeh S; Goodarzi N; Doroudian M; Movahed E
    Rev Med Virol; 2022 Jul; 32(4):e2321. PubMed ID: 34958163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication.
    Vaddadi K; Gandikota C; Huang C; Liang Y; Liu L
    Am J Physiol Cell Physiol; 2023 Aug; 325(2):C420-C428. PubMed ID: 37399496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review.
    Paul S; Bravo Vázquez LA; Reyes-Pérez PR; Estrada-Meza C; Aponte Alburquerque RA; Pathak S; Banerjee A; Bandyopadhyay A; Chakraborty S; Srivastava A
    Virus Res; 2022 Jan; 308():198631. PubMed ID: 34788642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection.
    Yang CY; Chen YH; Liu PJ; Hu WC; Lu KC; Tsai KW
    Int J Med Sci; 2022; 19(8):1340-1356. PubMed ID: 35928726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
    Dinda B; Dinda S; Dinda M
    Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
    Meng F; Siu GK; Mok BW; Sun J; Fung KSC; Lam JY; Wong NK; Gedefaw L; Luo S; Lee TMH; Yip SP; Huang CL
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs as emerging regulators of COVID-19.
    Liang Y; Fang D; Gao X; Deng X; Chen N; Wu J; Zeng M; Luo M
    Theranostics; 2023; 13(1):125-147. PubMed ID: 36593971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAs in SARS-CoV-2 Infection: An Update.
    Azhar A; Khan WH; Al-Hosaini K; Kamal MA
    Curr Drug Metab; 2022; 23(4):283-298. PubMed ID: 35319361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-COV-2 as potential microRNA sponge in COVID-19 patients.
    Li C; Wang R; Wu A; Yuan T; Song K; Bai Y; Liu X
    BMC Med Genomics; 2022 Apr; 15(Suppl 2):94. PubMed ID: 35461273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An albumin-angiotensin converting enzyme 2-based SARS-CoV-2 decoy with FcRn-driven half-life extension.
    Fuchs E; Rudnik-Jansen I; Dinesen A; Selnihhin D; Mandrup OA; Thiam K; Kjems J; Pedersen FS; Howard KA
    Acta Biomater; 2022 Nov; 153():411-418. PubMed ID: 36162760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Targeting ACE2 for Developing COVID-19 Therapeutics.
    Suvarnapathaki S; Chauhan D; Nguyen A; Ramalingam M; Camci-Unal G
    Ann Biomed Eng; 2022 Dec; 50(12):1734-1749. PubMed ID: 36261668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 encoded microRNAs are involved in the process of virus infection and host immune response.
    Liu Z; Wang J; Ge Y; Xu Y; Guo M; Mi K; Xu R; Pei Y; Zhang Q; Luan X; Hu Z; Chi Y; Liu X
    J Biomed Res; 2021 Jan; 35(3):216-227. PubMed ID: 33963094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.